Compounds > 2'-deoxycytidine 5'-triphosphate
Page last updated: 2024-08-24

2'-deoxycytidine 5'-triphosphate and Colonic Neoplasms

2'-deoxycytidine 5'-triphosphate has been researched along with Colonic Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergman, AM; Eijk, PP; Hubeek, I; Peters, GJ; Ruiz van Haperen, VW; Smid, K; van den Ijssel, P; Veerman, G; Ylstra, B1
Jiang, H; Li, L; Plunkett, W; Shen, Y; Yang, LY1
Allegra, CJ; Grem, JL1
Danhauser, LL; Rustum, YM1

Other Studies

4 other study(ies) available for 2'-deoxycytidine 5'-triphosphate and Colonic Neoplasms

ArticleYear
In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant.
    Cancer research, 2005, Oct-15, Volume: 65, Issue:20

    Topics: Animals; Blotting, Western; Colonic Neoplasms; Cytidine Deaminase; Deoxycytidine; Deoxycytidine Kinase; Deoxycytosine Nucleotides; Drug Resistance, Neoplasm; Female; Gemcitabine; Gene Expression Profiling; Mice; Mice, Inbred BALB C; Nucleoside Deaminases; Oligonucleotide Array Sequence Analysis; Protein Subunits; Ribonucleotide Reductases

2005
Expression of ERCC1 antisense RNA abrogates gemicitabine-mediated cytotoxic synergism with cisplatin in human colon tumor cells defective in mismatch repair but proficient in nucleotide excision repair.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:3

    Topics: Antineoplastic Agents; Base Pair Mismatch; Cell Survival; Cisplatin; Colonic Neoplasms; Deoxycytidine; Deoxycytosine Nucleotides; DNA; DNA Repair; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Endonucleases; Gemcitabine; Gene Expression; Humans; Mutation; Proteins; RNA, Antisense; Tumor Cells, Cultured

2000
Sequence-dependent interaction of 5-fluorouracil and arabinosyl-5-azacytosine or 1-beta-D-arabinofuranosylcytosine.
    Biochemical pharmacology, 1991, Jul-05, Volume: 42, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cell Division; Cell Line; Cell Nucleus; Cell Survival; Colonic Neoplasms; Cytarabine; Cytidine; Deoxycytosine Nucleotides; DNA, Neoplasm; Drug Administration Schedule; Drug Interactions; Fluorouracil; Humans; Nucleic Acids; Thymine Nucleotides; Tumor Stem Cell Assay

1991
Potential for selective enhancement of the in vivo metabolism of 1-beta-D-arabinofuranosylcytosine in rats by thymidine pretreatment.
    Cancer research, 1985, Volume: 45, Issue:5

    Topics: Animals; Biotransformation; Colonic Neoplasms; Cytarabine; Deoxycytosine Nucleotides; Drug Therapy, Combination; Female; Rats; Rats, Inbred F344; Thymidine; Thymine Nucleotides

1985